Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
01/05/2005 | CN1560245A Enzyme detoxicant and preparation process and application thereof |
01/05/2005 | CN1560243A Extracting process of actinidia proteinase |
01/05/2005 | CN1560079A Deep-processing method for animal blood |
01/05/2005 | CN1183157C Method for distillig active protein liquid of scorpion |
01/05/2005 | CN1183155C Peptide useful as ligand |
01/05/2005 | CN1183112C PEG-inerferon conjugate |
01/05/2005 | CN1182870C Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
01/04/2005 | US6838549 For treatment of leukemia; enhancing bone marrow recovery in allogeneic or autologous transplantation and in treatment, radiation, chemically, or chemotherapeutically induced aplasia or myelosuppression |
01/04/2005 | US6838113 Increasing the digestibility of food proteins by thioredoxin reduction |
01/04/2005 | CA2213577C A process for the preparation of factor ix from biological sources |
01/04/2005 | CA2187502C Sweetener salts |
12/30/2004 | US20040268440 Transgenic plants expressing cobalamin binding proteins |
12/30/2004 | US20040268425 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms |
12/30/2004 | US20040266695 Novel LHRH antagonists having improved solubility properties |
12/30/2004 | US20040266690 Formation of novel erythropoietin conjugates using transglutaminase |
12/30/2004 | US20040266683 Prevention and treatment of cardiac arrhythmias |
12/30/2004 | US20040265981 A cDna clone; culturing liver cell in coditioning media |
12/30/2004 | US20040265955 Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof |
12/30/2004 | US20040265949 Method and building blocks for preparing C-terminally labelled peptides |
12/30/2004 | US20040265944 Method for detecting post-translation modifications of peptides |
12/30/2004 | US20040265911 Peptides for use in culture media |
12/30/2004 | US20040265910 peptides which include cell-growth affecting peptides and peptides which enhance or inhibit production of cellular proteins formulated in culture medium to produce the desired effect on cultured cells; useful in concatemer-based recombinant expression methods |
12/30/2004 | US20040265899 Solid phase synthesis supports and methods |
12/30/2004 | US20040265838 Biochips/microarrays; quality control; solid phase synthesis |
12/30/2004 | US20040265298 Denaturing by first dissolving the protein with a chaotroph at high pH, refolding by dilution in the presence of reduced concentrations of chaotroph at low pH; forming a stable solution; purification; for the treatment of thrombosis |
12/30/2004 | US20040262216 Negatively charged membrane |
12/30/2004 | DE202004015263U1 Separation material for purifying His-tagged proteins, comprises carrier having a non-saturating concentration of active metal-chelating residues, allows elution at lower imidazole concentration |
12/29/2004 | WO2004113924A2 Method and system for generating and capturing peptides on a target surface |
12/29/2004 | WO2004113493A2 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
12/29/2004 | WO2004113362A2 Libraries containing heterocyclic organic molecules prepared through intramolecular formation of n-acyliminium ions |
12/29/2004 | WO2004112820A2 Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity |
12/29/2004 | WO2004112727A2 Aav virions with decreased immunoreactivity and uses therefor |
12/29/2004 | WO2004086050A3 Labelling agents for mass spectrometry comprising tertiary amines |
12/29/2004 | WO2004003564A3 Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases |
12/29/2004 | EP1492019A1 Method of forming molecule function network |
12/29/2004 | EP1491556A1 Humanized immunoglobulins and their production and use |
12/29/2004 | EP1491552A2 Method and apparatus for the microwave-assisted peptide synthesis |
12/29/2004 | EP1491208A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
12/29/2004 | EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
12/29/2004 | EP1490693A1 Method for characterising analytes |
12/29/2004 | EP1490677A2 Computational method for designing enzymes for incorporation of amino acid analogs into proteins |
12/29/2004 | EP1490394A1 Method and apparatus for the identification and qualification of biomolecules |
12/29/2004 | EP1490329A1 Production of carboxylic acid amides |
12/29/2004 | EP1409667B1 Process for preparing variant polynucleotides |
12/29/2004 | EP1343516A4 Analogues of thiocoraline and be-22179 |
12/29/2004 | EP1147137A4 Methods for generating phosphorylation site-specific immunological reagents |
12/29/2004 | EP0959975B1 Novel affinity ligands and their use |
12/29/2004 | CN1558914A Receptor, the use thereof, and mouse antibodies |
12/29/2004 | CN1558912A Method for making acylated polypeptides |
12/29/2004 | CN1558207A Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
12/29/2004 | CN1557950A Method of preparing lactoferritin and lactoperoxidase |
12/29/2004 | CN1557494A Preparation of microorganism resisting biological active component and its application |
12/29/2004 | CN1182240C Barm expressing system of plasminogen and purifying process |
12/29/2004 | CN1182154C Novel dolastatin derivatives, their preparation and use |
12/29/2004 | CN1182153C Novel dolastatin derivatives, their preparation and use |
12/29/2004 | CN1181911C Preparation of zeolite modified flyash microbead assembled bodies for having affinity and separation of protein |
12/29/2004 | CA2533480A1 Libraries containing heterocyclic organic molecules prepared through intramolecular formation of n-acyliminium ions |
12/29/2004 | CA2525379A1 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
12/28/2004 | US6835379 Removal of albumin resulting in an IgG fraction; purifying IgG from an IgG fraction, concentrating the IgG fraction; adjusting pH; carrying out the virus inactivation by using chemicals |
12/23/2004 | WO2004111646A1 Novel ms reagents |
12/23/2004 | WO2004111608A2 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions |
12/23/2004 | WO2004111557A1 Multiutility vapor compression system |
12/23/2004 | WO2004111075A2 Alternative reading frame polypeptides for treatment |
12/23/2004 | WO2004111072A2 Combinatorial nucleobase oligomers comprising universal base analogues and methods for making and using same |
12/23/2004 | WO2004110390A2 Anti-cd74 immunoconjugates and methods |
12/23/2004 | WO2004110367A2 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections |
12/23/2004 | WO2004076059A3 System and process for the synthesis of polymers |
12/23/2004 | WO2004074310A8 Mycobacterial diagnostics |
12/23/2004 | WO2004056317A3 Compositions for the treatment and prevention of nephropathy |
12/23/2004 | WO2003083436A3 Fibrinogen binding moieties |
12/23/2004 | US20040260418 Customized microfluidic device design, ordering, and manufacturing |
12/23/2004 | US20040260059 [microwave-assisted peptide synthesis] |
12/23/2004 | US20040260019 Zero length cross-linking of proteins and related compounds |
12/23/2004 | US20040259801 Ion exchanging a peptide; then salt formation; therapy for benign prostate hyperplasia; endometriosis |
12/23/2004 | US20040259221 separation of DNA binding nuclear proteins from a cellular sample before proteomic analysis using a volatile buffer such as ammonium bicarbonate such that no dialysis step is needed between extraction and separation steps |
12/23/2004 | US20040259162 container or multiwell plate for isolation of cellular components, such as polypeptides and nucleic acids, from host cells; interior surface comprising a sidewall formation and a bottom; a volume; a lytic reagent; and optionally a supported capture ligand |
12/23/2004 | US20040256324 Adsorption method and ligands |
12/23/2004 | CA2765196A1 Microwave-assisted peptide synthesis |
12/23/2004 | CA2529496A1 Anti-cd74 immunoconjugates and methods |
12/23/2004 | CA2528958A1 Combinatorial nucleobase oligomers comprising universal base analogues and methods for making and using same |
12/23/2004 | CA2528375A1 Macrocyclic antagonists of the motilin receptor |
12/23/2004 | CA2526753A1 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections |
12/23/2004 | CA2524325A1 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions |
12/23/2004 | CA2514288A1 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease |
12/22/2004 | EP1488004A2 Method of concentrating macromolecules or agglomerates of molecules or particles |
12/22/2004 | EP1487866A1 Novel polypeptide scaffolds and use thereof |
12/22/2004 | EP1487863A2 Process for purifying glycopeptide phospohonate derivatives |
12/22/2004 | EP1487862A2 Polymer supported reagents for natural products purification |
12/22/2004 | EP1487861A2 Treating solution containing aluminium ion for staining protein and staining method using the same |
12/22/2004 | EP1487860A1 Compounds comprising pseudo-amino acids |
12/22/2004 | EP1487762A1 Radiofluorination methods |
12/22/2004 | EP1487280A1 Compositions and methods for eliciting an immune response to gram-negative bacterial infections |
12/22/2004 | EP1230258A4 Multi-compartment electrophoresis |
12/22/2004 | EP1177311A4 In vitro macromolecule biosynthesis methods using exogenous amino acids and a novel atp regeneration system |
12/22/2004 | EP1001968B1 Solid phase native chemical ligation of unprotected or n-terminal cysteine protected peptides in aqueous solution |
12/22/2004 | CN1556206A Renaturation separation purification method of tissue plasminogen activator mutant |
12/22/2004 | CN1181341C Method of using nano zeolite molecular sieve assemble material as affinity chromatography filler to separate functional protein molecules |
12/22/2004 | CN1181198C Preparing method for acetylchloinesterase |
12/22/2004 | CN1181098C Monoclonal antibody to alpha 2-macroglobulin and its use for detecting glucan |
12/22/2004 | CN1181093C Extraction of integral membrane proteins |